Is a complete BCBA/JNJ research report available?

No complete published report is available for bcba/JNJ (BCBA/JNJ) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

bcba/JNJ stock profile: metrics, valuation and analysis

Market cap	967.4T
Revenue (ttm)	144.4T
Net income (ttm)	31T
EPS (ttm)	ARS 12,718
P/E (trailing)	31.2x
P/E (forward)	22.7x
Dividend	ARS 316 (1.11%)
Volume	9,213
Beta	0.23

All BCBA/JNJ indicators

Market & fundamental data

Available fields

244

Groups with data

Currency

USD

Showing 244 of 244 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	138,200
Employees Change	6,200%
Employees Change Percent	4.7
Enterprise value	ARS 1010.1T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - General
Isin	ARDEUT110236
Last refreshed	2026-09-12
Market cap	ARS 967.4T
Price	ARS 28,360
Price currency	ARS
Rev Per Employee	1,044,623,240.23x
Sector	Healthcare
Sic	2834
Symbol	bcba/JNJ
Website	https://www.jnj.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.21%
EV Earnings	32.57x
EV/EBIT	24.64x
EV/EBITDA	19.06x
EV/FCF	30.8x
EV/Sales	6.82x
FCF yield	3.39%
Forward P/E	22.7x
P/B ratio	7.72x
P/E ratio	31.19x
P/S ratio	6.7x
PE Ratio10 Y	46x
PE Ratio3 Y	18.31x
PE Ratio5 Y	21.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	27.69%
EBITDA Margin	35.61%
FCF margin	22.19%
Gross margin	68.14%
Gross Profit	ARS 98.4T
Gross Profit Growth	7.63%
Gross Profit Growth Q	7.22%
Gross Profit Growth3 Y	5.43%
Gross Profit Growth5 Y	2.23%
Net Income	ARS 31T
Net Income Growth	-7.17%
Net Income Growth Q	-0.05%
Net Income Growth Qo Q	5.71%
Net Income Growth3 Y	17.24%
Net Income Growth5 Y	3.44%
Pretax Margin	25.73%
Profit Margin	21.48%
Profit Per Employee	ARS 224.4M
ROA	8.59
Roa5y	8.04
ROCE	18.55
ROE	25.74
Roe5y	24.21
ROIC	19.92
Roic5y	23.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	75.08%
Cagr15y	64.56%
Cagr1y	71.37%
Cagr20y	49.04%
Cagr3y	55.5%
Cagr5y	71.41%
Div CAGR10	5.95%
Div CAGR3	4.15%
Div CAGR5	5.91%
EPS Growth	-7.58
EPS Growth Q	-0.87
EPS Growth Qo Q	6.07
EPS Growth3 Y	20.48
EPS Growth5 Y	5.34
FCF Growth	19.92%
FCF Growth Q	157.32%
FCF Growth Qo Q	397.95%
FCF Growth3 Y	15.21%
FCF Growth5 Y	-0.29%
OCF Growth	19.89%
OCF Growth Q	122.18%
OCF Growth Qo Q	242.72%
OCF Growth10 Y	4.38%
OCF Growth3 Y	13.12%
OCF Growth5 Y	1.12%
Revenue Growth	8.06x
Revenue Growth Q	6.6x
Revenue Growth Qo Q	5.19x
Revenue Growth3 Y	5.95x
Revenue Growth5 Y	1.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.5
Assets	ARS 296.4T
Cash	ARS 30.6T
Current Assets	ARS 90.2T
Current Liabilities	ARS 82.9T
Debt	ARS 72.3T
Debt EBITDA	ARS 1.4
Debt Equity	ARS 0.58
Debt FCF	ARS 2.2
Equity	ARS 125.3T
Interest Coverage	26.8
Liabilities	ARS 171.1T
Long Term Assets	ARS 206.2T
Long Term Liabilities	ARS 88.3T
Net Cash	ARS -41.7T
Net Cash By Market Cap	ARS -4.31
Net Debt EBITDA	ARS 0.81
Net Debt Equity	ARS 0.33
Net Debt FCF	ARS 1.27
Tangible Book Value	ARS -17.3T
Tangible Book Value Per Share	ARS -7,185
WACC	5.28

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.09
Inventory Turnover	2.19
Net Working Capital	ARS -6.2T
Quick ratio	0.73
Working Capital	ARS 7.2T
Working Capital Turnover	ARS 55,558

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.53%
Dividend Growth	3.25%
Dividend Growth Years	24%
Dividend per share	ARS 316
Dividend Years	29
Dividend Yield	1.11%
Ex Div Date	2026-08-25
Last Dividend	ARS 0.06
Payout Frequency	Quarterly
Payout Ratio	59.99%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	26,947.85%
1Y total return	71.31%
200-day SMA	23,990.3
3Y total return	276.11%
50-day SMA	27,788.4
50-day SMA vs 200-day SMA	50over200
5Y total return	1,379.32%
All Time High	30,080
All Time High Change	-5.72%
All Time High Date	2026-09-07
All Time Low	3.1
All Time Low Change	914,738.71%
All Time Low Date	2001-04-26
ATR	730
Beta	0.24
Ch YTD	34.86
High	28,840
High52	30,080
High52 Date	2026-09-07
High52ch	-5.72%
Low	28,240
Low52	16,010
Low52 Date	2025-09-23
Low52ch	77.14%
Ma50ch	2.06%
Price vs 200-day SMA	18.21%
RSI	50.23
RSI Monthly	81.37
RSI Weekly	66.42
Sharpe ratio	2.04x
Sharpe Ratio3y	1.48x
Sharpe Ratio5y	1.77x
Sortino ratio	3.24
Sortino Ratio3y	2.54
Sortino Ratio5y	3.05
Total Return	0.58%
Tr YTD	36.4
Tr15y	175,706.1%
Tr1m	3.38%
Tr1w	-2.61%
Tr3m	18.52%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,405,987,057%
Net Borrowing	-2,372,683,273,860
Shares Insiders	0.04%
Shares Institutions	76.38%
Shares Qo Q	-0.21%
Shares Yo Y	0.53%
Short Ratio	2.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 30.7T
Adjusted OCF	38,615,194,800,000
Average Volume	11,356x
Bv Per Share	52,015.1
CAPEX	ARS -7.9T
Ch10y	23,533.3
Ch15y	143,009.5
Ch1m	2.9
Ch1w	-2.61
Ch1y	68.71
Ch20y	216,935.3
Ch3m	17.97
Ch3y	258.5
Ch5y	1,286.3
Ch6m	19.06
Change	0%
Change From Open	-1.12
Close	28,360
Days Gap	1.13
Depreciation Amortization	11,698,898,254,255
Dollar Volume	261,280,680
Earnings Date	2026-10-13
EBIT	ARS 40T
EBITDA	ARS 51.4T
EPS	ARS 12,718
F Score	7
FCF	ARS 32.8T
FCF EV Yield	3.25x
Financing CF	-27,336,090,600,000
Fiscal Year End	December
Founded	1,886
Goodwill	73,171,318,341,895
Graham Number	8667.20111
Graham Upside	-69.44
Income Tax	ARS 6.1T
Investing CF	-10,580,333,400,000
Is Primary Listing	0
Last Earnings Date	2026-07-15
Last Report Date	2026-06-28
Last Split Date	2022-11-17
Last Split Type	Forward
Lynch Fair Value	ARS 4,546
Lynch Upside	-83.97
Ma150	24,886.8
Ma150ch	13.96%
Ma20	28,724
Ma20ch	-1.27%
Net CF	2,719,899,000,000
Next Earnings Date	2026-10-13
Open	28,680
P FCF Ratio	29.5
P FCF Ratio SBC	31.5
P OCF Ratio	23.77
P OCF Ratio SBC	25.05
Payment Date	2026-09-08
Position In Range	20
Ppne	35,593,267,788,910
Price Date	2026-09-11
Price EBITDA	ARS 18.82
Relative Volume	0.81x
Revenue	144,366,931,800,000x
SBC By Revenue	1.44x
Share Based Comp	2,084,518,800,000
Tax By Revenue	4.25x
Tax Rate	16.51%
Tr20y	292,314.09%
Tr6m	20.03%
Volume	9,213
Z Score	4.74

BCBA/JNJ (BCBA/JNJ)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/JNJ

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/JNJ indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on BCBA/JNJ

Frequently asked questions